Roche arthritis drug cuts deaths in hospitalized COVID-19 patients, study suggests | CBC News
Tocilizumab Actemra 400mg by cipla Roche at Rs 39000/vial | Tocilizumab Injection in Ahmedabad | ID: 25556328448
Tocilizumab Injection Supply: Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of Tocilizumab - The Economic Times
Is PMR the Next Indication for Tocilizumab? | MedPage Today
Roche's arthritis drug lowers deaths in hospitalised Covid-19 patients
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
Roche's Actemra fails to meet Phase III goals in Covid-19 patients
Genentech's arthritis drug tocilizumab shows promise in Covid-19 trial
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
USTC Global on X: "The mechanism of using Tocilizumab to cure severe patients of COVID-19. @NIH @CDC @DrAiLynTan #coronavirus #COVID19 #CoronavirusOutbreak #coronaviruskorea #ItalyCoronavirus #italylockdown #IranCoVidTruth #Tocilizumab https://t.co ...
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
Health System News Teamwork Tackles Tocilizumab
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates - ABC News
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
Approval lapsed) RoActemra tocilizumab 80mg/4mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
WHO adds Roche's arthritis drug tocilizumab to COVID-19 medicines list | Reuters
FDA approves Roche's Actemra COVID-19 trial - PMLiVE
Roche warns of shortage of Covid-19 drug tocilizumab - The Hindu BusinessLine
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QFWUTH5BLZN5LGWVT27LGWPZBE.jpg "Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters")
Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters
Tocilizumab Raises GI Risks in Rheumatoid Arthritis | MedPage Today
Roche Suspends Patents On Tocilizumab In LMICs After WHO Recommends It As Treatment For Severe COVID-19 - Health Policy Watch
WHO Urges Covid-19 Treatment With Roche and Sanofi Anti-Inflammatory Drugs - WSJ
Actemra; coronavirus complications to be treated under Chinese approval
